Technology | November 02, 2011

Low Dose Molecular Breast Imaging Aids Tumor Detection

Gamma Medica Inc. will demonstrate the LumaGEM Low Dose Molecular Breast Imaging (MBI) System at RSNA 2012. 

LumaGEM MBI is the first commercially available, U.S. Food and Drug Administration (FDA)-cleared, planar, dual-head, fully solid state digital imaging system utilizing cadmium zinc telluride (CZT) technology used for digital breast imaging.  LumaGEM Low Dose MBI is a major advancement in the area of molecular imaging, identifying tumors in dense breast tissue that are often not visible with mammography. 

A 2011 publication in Radiology (doi:10.1148/radiol.10100625), documented the addition of molecular breast imaging (MBI) in 1,000 patients, following an injection of 20 mCi Tc-99m sestamibi, to screening mammography (MG) significantly increased detection of breast cancer in dense breasts from 27 percent with MG alone to 91 percent with the combination (p=0.016).

After implementing modifications that permit further radiation dose reduction, performance has been clinically compared between screen mammography and prevalent screen low-dose MBI in 2,400 women with dense breasts using an 8 mCi injection of Tc-99m sestamibi, dual-head CZT detectors by Gamma Medica, and acquired in dynamic frames to allow the generation of 4 mCi equivalent images.

For more information:

Related Content

The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
X-ray performed on a GE Optima 646 DR system. The FDA has updated its radiology reporting forms on its website.
News | Business | July 24, 2017
July 24, 2017 — The U.S.
Kubtec Launches New Website For Digital Imaging and Irradiation Products
News | Digital Radiography (DR) | July 20, 2017
Kubtec announced the launch a new website focused on the applications of digital X-ray imaging and irradiation for...
Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017
News | Digital Radiography (DR) | July 06, 2017
Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and...
Feature | Breast Density | July 05, 2017 | By Nancy M. Cappello, Ph.D.
Two decades of research on the masking risk of dense breast tissue by mammography screening is indisputable. As the...
Solis Mammography Ranks No. 19 in Dallas Business Journal’s Middle Market 50
News | Mammography | June 30, 2017
June 30, 2017 — Solis Mammography was named the 19th fastest-growing, middle-market company in North Texas by the
GE Healthcare Announces First U.S. Installation of Senographe Pristina Mammography System
News | Mammography | June 29, 2017
GE Healthcare has collaborated with Boca Raton Regional Hospital (Boca Raton, Fla.) to bring a more comfortable...
New Study Highlights Breakthrough Therapy to Reduce Mammographic Breast Density
News | Breast Density | June 28, 2017
Stephen N. Birrell, M.D., Ph.D., presented breakthrough findings into the reduction of mammographic breast density at...
Overlay Init